We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+13.24%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.98B
AUM Growth
-$507M
Cap. Flow
-$797M
Cap. Flow %
-20.01%
Top 10 Hldgs %
20.37%
Holding
959
New
177
Increased
246
Reduced
253
Closed
277

Sector Composition

Rank Sector Weight
1 Technology 16.81%
2 Consumer Discretionary 13.07%
3 Industrials 12.35%
4 Healthcare 11.57%
5 Communication Services 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBST
326
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$3.3M 0.08%
47,868
-315,617
-87% -$20.4M
CTIC
327
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.29M 0.08%
+171,386
New +$3.12M
THS
328
DELISTED
Treehouse Foods
THS
$3.28M 0.08%
47,593
-8,985
-16% -$632K
CDNS icon
329
Cadence Design Systems
CDNS
$93.2B
$3.27M 0.08%
233,040
-233,142
-50% -$3.13M
TIMB icon
330
TIM SA
TIMB
$8.85B
$3.25M 0.08%
+123,680
New +$3.12M
RH icon
331
RH
RH
$3.56B
$3.23M 0.08%
47,965
-39,965
-45% -$2.74M
AEIS icon
332
Advanced Energy
AEIS
$13B
$3.21M 0.08%
+140,578
New +$3.01M
MSCI icon
333
MSCI
MSCI
$41.2B
$3.21M 0.08%
73,378
-42,324
-37% -$1.78M
ITMN
334
DELISTED
INTERMUNE INC
ITMN
$3.17M 0.08%
215,130
-405,418
-65% -$5.6M
SIMG
335
DELISTED
SILICON IMAGE INC
SIMG
$3.16M 0.08%
513,806
+24,255
+5% +$131K
SGNT
336
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$3.15M 0.08%
124,065
-138,343
-53% -$3.12M
PVA
337
DELISTED
PENN VIRGINIA CORP
PVA
$3.15M 0.08%
+333,579
New +$3.02M
DENN
338
DELISTED
Denny's
DENN
$3.12M 0.08%
434,418
-332,396
-43% -$2.26M
AVGO icon
339
Broadcom
AVGO
$2T
$3.12M 0.08%
+590,060
New +$2.71M
TX icon
340
Ternium
TX
$10.2B
$3.11M 0.08%
99,304
-75,520
-43% -$2.07M
CNQ icon
341
Canadian Natural Resources
CNQ
$94.8B
$3.1M 0.08%
189,773
-48,327
-20% -$751K
TSRO
342
DELISTED
TESARO, Inc.
TSRO
$3.09M 0.08%
109,339
+21,253
+24% +$788K
MYRG icon
343
MYR Group
MYRG
$5.16B
$3.07M 0.08%
122,260
-12,452
-9% -$312K
CZR
344
DELISTED
Caesars Entertainment Corporation
CZR
$3.04M 0.08%
140,982
-717,868
-84% -$14M
HZNP
345
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3M 0.08%
+393,593
New +$2.12M
NG icon
346
NovaGold Resources
NG
$3.03B
$2.96M 0.07%
1,163,710
-1,142,776
-50% -$2.6M
AZPN
347
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$2.92M 0.07%
69,859
-282,429
-80% -$11.8M
IDTI
348
DELISTED
Integrated Device Technology I
IDTI
$2.91M 0.07%
285,582
+40,374
+16% +$402K
NVO
349
Novo Nordisk
NVO
$203B
$2.89M 0.07%
156,450
+49,510
+46% +$863K
BIO icon
350
Bio-Rad Laboratories Class A
BIO
$9.16B
$2.88M 0.07%
23,339
-28,830
-55% -$3.51M

Similar funds

Oxford Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, Oxford Asset Management held 959 positions worth $3.98B, down 11% from $4.49B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oxford Asset Management withdrew a net $797M in Q4 2013, closing 277 positions and reducing 253 holdings. Its most notable exit was ELAN CORP ADS(RP1 ORD4IRISH PN, an estimated $400M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Oxford Asset Management opened a new position in VIROPHARMA INC worth $153M.

  • Oxford Asset Management's largest Q4 2013 buy was VIROPHARMA INC: 3,059,478 shares worth $153M.
  • Oxford Asset Management added most to GIANT INTERACTIVE GROUP INC ADR (CAYMAN ISLANDS) in Q4 2013, an estimated $115M increase.
  • Oxford Asset Management's biggest Q4 2013 reduction was Spirit AeroSystems, cutting an estimated $25.4M.
  • Oxford Asset Management fully exited ELAN CORP ADS(RP1 ORD4IRISH PN in Q4 2013, selling an estimated $400M.
  • Oxford Asset Management's ten largest holdings make up 20% of its $3.98B portfolio in Q4 2013.
  • Oxford Asset Management opened 177 new positions and closed 277 in Q4 2013.
  • Oxford Asset Management's portfolio value fell 11% quarter-over-quarter to $3.98B.

Based on Oxford Asset Management's 13F filing for Q4 2013, filed 22 Jan 2014.